Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.
Uchino K, Mizuno S, Mizutani M, Horio T, Hanamura I, Espinoza JL, Matsuo K, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori TM, Takami A; Japan Marrow Donor Program. Uchino K, et al. Among authors: hanamura i. Transpl Immunol. 2016 Sep;38:60-6. doi: 10.1016/j.trim.2016.06.002. Epub 2016 Jun 28. Transpl Immunol. 2016. PMID: 27369862
Toll-like receptor genetic variations in bone marrow transplantation.
Uchino K, Mizuno S, Sato-Otsubo A, Nannya Y, Mizutani M, Horio T, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Ogawa S, Takami A. Uchino K, et al. Among authors: hanamura i. Oncotarget. 2017 Jul 11;8(28):45670-45686. doi: 10.18632/oncotarget.17315. Oncotarget. 2017. PMID: 28484092 Free PMC article.
The recipient CCR5 variation predicts survival outcomes after bone marrow transplantation.
Horio T, Mizuno S, Uchino K, Mizutani M, Hanamura I, Espinoza JL, Onizuka M, Kashiwase K, Morishima Y, Fukuda T, Kodera Y, Doki N, Miyamura K, Mori T, Takami A. Horio T, et al. Among authors: hanamura i. Transpl Immunol. 2017 Jun;42:34-39. doi: 10.1016/j.trim.2017.05.003. Epub 2017 May 6. Transpl Immunol. 2017. PMID: 28487238
Establishment and characterization of a novel vincristine-resistant diffuse large B-cell lymphoma cell line containing the 8q24 homogeneously staining region.
Mizuno S, Hanamura I, Ota A, Karnan S, Kanasugi J, Nakamura A, Takasugi S, Uchino K, Horio T, Goto M, Murakami S, Gotou M, Yamamoto H, Watarai M, Shikami M, Hosokawa Y, Miwa H, Taniwaki M, Ueda R, Nitta M, Takami A. Mizuno S, et al. Among authors: hanamura i. FEBS Open Bio. 2018 Nov 20;8(12):1977-1991. doi: 10.1002/2211-5463.12538. eCollection 2018 Dec. FEBS Open Bio. 2018. PMID: 30524948 Free PMC article.
Efficacy and safety of autologous stem cell transplantation in patients aged ≥ 65 years with multiple myeloma in the era of novel agents.
Mizuno S, Kawamura K, Hanamura I, Sunami K, Mori T, Nakamura F, Iida S, Nakazawa H, Makita M, Kako S, Sawa M, Ueda Y, Takahashi H, Kanda Y, Ichinohe T, Atsuta Y, Takamatsu H, Takami A. Mizuno S, et al. Among authors: hanamura i. Bone Marrow Transplant. 2019 Oct;54(10):1595-1604. doi: 10.1038/s41409-019-0478-4. Epub 2019 Feb 19. Bone Marrow Transplant. 2019. PMID: 30783208
Immunomodulatory and Metabolic Changes after Gnetin-C Supplementation in Humans.
Nakagami Y, Suzuki S, Espinoza JL, Vu Quang L, Enomoto M, Takasugi S, Nakamura A, Nakayama T, Tani H, Hanamura I, Takami A. Nakagami Y, et al. Among authors: hanamura i. Nutrients. 2019 Jun 21;11(6):1403. doi: 10.3390/nu11061403. Nutrients. 2019. PMID: 31234376 Free PMC article. Clinical Trial.
85 results